Breast and ovarian cancer risk management in a French cohort of 158 women carrying a BRCA1 or BRCA2 germline mutation: patient choices and outcome.

MLA

This, Pascale, et al. “Breast and Ovarian Cancer Risk Management in a French Cohort of 158 Women Carrying a BRCA1 or BRCA2 Germline Mutation: Patient Choices and Outcome.” Familial Cancer, vol. 11, no. 3, Sept. 2012, pp. 473–82. EBSCOhost, https://doi.org/10.1007/s10689-012-9539-1.

APA

This, P., de la Rochefordière, A., Savignoni, A., Falcou, M. C., Tardivon, A., Thibault, F., Alran, S., Fourchotte, V., Fitoussi, A., Couturaud, B., Dolbeault, S., Salmon, R. J., Sigal-Zafrani, B., Asselain, B., & Stoppa-Lyonnet, D. (2012). Breast and ovarian cancer risk management in a French cohort of 158 women carrying a BRCA1 or BRCA2 germline mutation: patient choices and outcome. Familial Cancer, 11(3), 473–482. https://doi.org/10.1007/s10689-012-9539-1

Chicago

This, Pascale, Anne de la Rochefordière, Alexia Savignoni, Marie Christine Falcou, Anne Tardivon, Fabienne Thibault, Séverine Alran, et al. 2012. “Breast and Ovarian Cancer Risk Management in a French Cohort of 158 Women Carrying a BRCA1 or BRCA2 Germline Mutation: Patient Choices and Outcome.” Familial Cancer 11 (3): 473–82. doi:10.1007/s10689-012-9539-1.